AzTrials
AzTrials

HospitalizationSCOPE HPENCT06420128

Interprofessional Collaborative Practice in Primary Care: Potentially Avoidable Hospitalization

An observational study of Hospitalization and Aged, run by Nantes University Hospital at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The World Health Organization supports collaborative practice in primary care, defining it as "when multiple health professionals from different professional backgrounds work together with patients, families, carers and communities to deliver the highest quality of care across settings" (1). Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Hospitalization, Aged, Primary Health Care
What is being tested?
Primary care team
How many people
500,000 participants
Where
1 siteFrance
Study dates
Jun 2024to Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Older adult

Study population: Seniors

Who may be able to join

  • Patients over 75 years old and over 65 years old with chronic disease(s), with a general practitioner in Pays de la Loire, affiliated with the general health insurance system and have had at least one healthcare encounter, and residing in the Pays de la Loire region.

Who cannot join

  • Patients whose general practitioner has ceased their practice or changed their affiliation, as well as patients who have switched to a new general practitioner.

Trial locations and contacts

1 site in 1 country.

Cédric Rat, Doctor contact

02.40.41.28.28

cedric.rat@univ-nantes.fr

France1 site
  • University Hospital

    Nantes, 44093

    Cédric RAT, Doctor, 02.40.41.28.28, cedric.rat@univ-nantes.fr

Other trials in France

About this study

Official title: Collaborative Practice in Primary Care: a Comparison of the Global Rate of Potentially Avoidable Hospitalization, Depending on Whether Their General Practitioner is Part of a Primary Care Team. A Cohort Study With a 36-month Follow-up.

The World Health Organization supports collaborative practice in primary care, defining it as "when multiple health professionals from different professional backgrounds work together with patients, families, carers and communities to deliver the highest quality of care across settings" (1). Previous research have shown that collaborative practice in primary care improves care pathways, efficiency of care (2,3), job satisfaction among health professionals (4-6), and economic efficiency (3,7). Riverin et al. found a reduction in post-hospitalization mortality with collaborative practice (8).

In France, the establishment of primary care teams following the American model of Centered Medical Homes is encouraged. In the Pays de la Loire region, two models exist: A national and a regional model.

Read more

A major issue for patient care team is the care of seniors (9,10).Hospitalizations can have adverse health effects for this population (11,12). 45% of emergency admissions follow by a hospitalization concern them (13).

The hypothesis of the study is that collaborative practice could reduce the global rate of potential avoidable hospitalizations among seniors.

Being tested
Primary care team
Keywords
Collaborative practice, Seniors, Potentially avoidable hospitalization, Primary Care Team

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Primary care teamOther

    Patients whose general practitioner is a member of a primary care team since at least 12 months

Study groups in NCT06420128
Study groupRoleWhat they receive
Primary care teamPatients whose general practitioner is a member of a primary care team since at least 12 months
Receives: Other: Primary care team
TraditionalPatients whose general practitioner is not part of a primary care team

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison of Global rate of potentially avoidable hospitalization

    Comparison of the global rate of potentially avoidable hospitalization of seniors, depending on whether their general practitioner is a member of a primary care team. Use of reimbursement data of Health Insurance System.

    Measured: 36 months

Secondary outcomes (3)
  1. Comparison of criterion of quality

    Comparison of criterion of quality (rate of potentially avoidable hospitalization with emergency enter, rate of potentially avoidable hospitalization for patients with chronic disease(s), rate of rehospitalization at one month, mortality in post-hospitalization and rate of emergency admission), depending on whether their general practitioner is a member of a primary care team. Use of reimbursement data of Health Insurance System.

    Measured: 36 months

  2. Comparison of Global rate of potentially avoidable hospitalization depending the model of primary care team

    Comparison of Global rate of potentially avoidable hospitalization depending the model of primary care team Description: comparison of global rate of potentially avoidable hospitalization depending general practitioner is a member of a national model of primary care team or a regional model of primary care team. Use of reimbursement data of Health Insurance System.

    Measured: 36 months

  3. Medico-economic evaluation

    To determine health expenditures per patient, annual and total. Use of reimbursement data of Health Insurance System.

    Measured: 36 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 May 2024
  2. Study startJun 2024 (estimated)
  3. Primary completionDec 2024 (estimated)
  4. Study completionDec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
500,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06420128
Sponsor's protocol ID
RC21_0307
Acronym
SCOPE HPE
Status last verified
May 2024
First submitted
3 May 2024
Last updated
17 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hospitalization and Aged, run by Nantes University Hospital at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Cédric Rat, Doctor (02.40.41.28.28, cedric.rat@univ-nantes.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison of Global rate of potentially avoidable hospitalization (time frame: 36 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 May 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in